<DOC>
	<DOCNO>NCT00714740</DOCNO>
	<brief_summary>The purpose study investigate effect acetazolamide treatment sleep relate breathing disturbance patient obstructive sleep apnea syndrome live low altitude sojourn moderate altitude</brief_summary>
	<brief_title>Treatment Patients With Obstructive Sleep Apnea Syndrome Altitude</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Obstructive sleep apnea syndrome , successfully CPAP therapy Residence low altitude ( &lt; 800m ) Obstructive apnea/hypopnea index &gt; 20/h complaint excessive daytime sleepiness introduction CPAP therapy . &gt; 15 oxygen desaturations/h ( &gt; 3 % dip ) ambulatory nocturnal pulse oximetry perform end 4night period without CPAP Sleep disorder OSA . More mild cardiovascular disease , unstable recently diagnose ( within last 6 month ) cardiovascular disease arterial hypertension , coronary artery cerebrovascular disease . Any lung disease , pulmonary hypertension . Chronic rhinitis . Treatment drug affect respiratory center drive ( benzodiazepines sedative sleep induce drug , morphine codeine derivates ) , stimulant ( modafinil , methylphenidate , theophylline ) Internal , neurologic psychiatric disease interfere sleep quality . Previous intolerance moderate low altitude ( &lt; 2600m ) . Exposure altitudes &gt; 1500m &gt; 1 day within last 4 week study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>apnea , sleep , altitude , hypoxia</keyword>
</DOC>